Nuvalent Inc vs Teladoc Health Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Teladoc Health Inc trades at $9.7 (market cap $1.74B). The key difference: Nuvalent Inc is far larger — about 5.6× Teladoc Health Inc's market cap. Which is the better fit depends on your goals.
| NUVL | TDOC | |
|---|---|---|
Market Cap | $9.81B | $1.74B |
Sector | Technology | Health |
52-Week High | $123.96 | $9.72 |
52-Week Low | $72.16 | $4.47 |
Enterprise Value | $8.52B | $2.03B |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →